BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30590590)

  • 41. Safety Profile of Biologic Drugs in the Therapy of Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.
    Moćko P; Kawalec P; Pilc A
    Pharmacotherapy; 2016 Aug; 36(8):870-9. PubMed ID: 27312826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
    Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
    Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
    Sutherland LR; May GR; Shaffer EA
    Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.
    Vuitton L; Peyrin-Biroulet L; Colombel JF; Pariente B; Pineton de Chambrun G; Walsh AJ; Panes J; Travis SP; Mary JY; Marteau P
    Aliment Pharmacol Ther; 2017 Mar; 45(6):801-813. PubMed ID: 28112419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are endoscopic endpoints reliable in therapeutic trials of ulcerative colitis?
    Wolff S; Terheggen G; Mueller R; Greinwald R; Franklin J; Kruis W
    Inflamm Bowel Dis; 2013 Nov; 19(12):2611-5. PubMed ID: 24108110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Shah SC; Colombel JF; Sands BE; Narula N
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1245-1255.e8. PubMed ID: 26829025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.
    Mao EJ; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 Jan; 45(1):3-13. PubMed ID: 27862107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.
    Sandborn WJ; Cyrille M; Hansen MB; Feagan BG; Loftus EV; Rogler G; Vermeire S; Cruz ML; Yang J; Boedigheimer MJ; Abuqayyas L; Evangelista CM; Sullivan BA; Reinisch W
    Gastroenterology; 2019 Mar; 156(4):946-957.e18. PubMed ID: 30472236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis.
    Yoshimura N; Watanabe M; Motoya S; Tominaga K; Matsuoka K; Iwakiri R; Watanabe K; Hibi T;
    Gastroenterology; 2015 Dec; 149(7):1775-1783.e2. PubMed ID: 26327130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
    Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis.
    Zeng J; Lv L; Mei ZC
    J Gastroenterol Hepatol; 2017 Mar; 32(3):558-566. PubMed ID: 27699863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Singh S; Stroud AM; Holubar SD; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2015 Nov; (11):CD001176. PubMed ID: 26593456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
    Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
    Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
    Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A meta-analysis of antibiotic therapy for active ulcerative colitis.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Dig Dis Sci; 2007 Nov; 52(11):2920-5. PubMed ID: 17415632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis of the placebo response in ulcerative colitis.
    Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
    Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.